Scope & limitations
The administrative category includes HSAN IV and V. Its scope is wider than NTRK1-CIPA.
About these terms
- HSAN IV
- Where a resource says HSAN IV, it usually means CIPA. MedlinePlus Genetics states that CIPA “is also known as hereditary sensory and autonomic neuropathy type IV”, lists HSAN type IV and HSAN4 as alternative names, and identifies NTRK1 as the gene involved.Based on: MedlinePlus Genetics, U.S. National Library of Medicine
Record details
- Source organization
- Japan Intractable Diseases Information Center
- Regions
- Japan
- Research record date
- 2026-09-21This is not the medical revision date.
- Publication status
- Publication review complete
Title, version & context
- Index title
- Designated intractable disease 130: professional and public information
- Version & date
- Professional information (entry 4361): April 2024. Public information (4360) and FAQ (4362): November 2023. Research-group roster: June 2026.
- Source title
先天性無痛無汗症（指定難病１３０）
- Relationship to CIPA
- Explicitly includes CIPA.
Reading notes
- Main audience
- Healthcare professionals; patients and families can use the public-information and FAQ tabs.
- Resource purpose
- Consult the professional overview, diagnostic criteria and guidance sources, with attention to the scope of Japan’s disease designation.
Individual diagnosis and treatment require assessment by a physician.